Validating a risk score for lung disease patients with pulmonary hypertension
Part of Heart & circulation, Lungs & breathing clinical trials.
This study is testing whether a new risk score can better predict outcomes for people who have both chronic lung disease and pulmonary hypertension (high blood pressure in the lungs). If you qualify, the researchers will follow your health over time to see how well the score works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a chronic lung disease like COPD, pulmonary fibrosis, or advanced sarcoidosis, confirmed by a CT scan or lung function tests.
- You have been diagnosed with pulmonary hypertension (high blood pressure in the lungs) via a right-heart catheterization.
- You are willing to come back for follow-up visits and be available by phone.
- You are able to complete tests that may include walking or other physical activities.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks natural changes in “biomarkers” (measurable signals in blood) and imaging findings in people with pulmonary arterial hypertension (PAH) or suspected PAH. It also includes healthy people for comparison, helping researchers understand what these signals mean over time.
This study looks at how pulmonary arterial hypertension (PAH) affects lean muscle mass. It aims to understand the relationship between PAH and muscle loss, which could help improve treatments and quality of life.
This study aims to better predict the future risk for people with pulmonary hypertension (high blood pressure in the lungs) by combining different types of health information collected over time. If you join, researchers will track your health data to build a tool that personalizes care and improves outcomes.
This study looks at lung tissue from surgery to learn how pulmonary hypertension (high blood pressure in the lungs) develops in people with lung disease. The goal is to find better ways to diagnose and treat this condition.
This study is tracking people with pulmonary hypertension (high blood pressure in the lungs) over time to see how their condition and quality of life change. By joining, you help doctors better understand the disease and improve care for others like you.
This study checks how safe pulmonary hypertension–targeted medicines (and some calcium-blocking medicines) are over time. It uses a computer system to follow you after diagnosis, looking at outcomes and side effects.
Hear when a new Chronic Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.